REDWOOD CITY, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that its presentation at the JPMorgan 24th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, on Thursday, January 12th will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at www.maxygen.com.
Russell Howard, chief executive officer, and Elliot Goldstein, chief operating officer, will provide an overview of the Company, its progress in key development programs and updated financial guidance. The presentation will be delivered at 1:30 p.m. (PT). The presentation will be archived for 90 days.
The presentation will include discussion of non-GAAP financial measures. Reconciliation of the non-GAAP financial measures to the most directly applicable GAAP measures can be found at www.maxygen.com under the “News- Financial Reconciliations” tab.
Maxygen, Inc., headquartered in Redwood City, California, is focused on the development of superior versions of validated major protein pharmaceuticals. Maxygen’s technologies bring together advances in molecular biology and protein modification to create novel biotechnology products. The Company has over 120 U.S. and foreign patents relating to its MolecularBreeding directed evolution platform.
Maxygen, Inc.
CONTACT: Jeannine Medeiros, Investor and Public Relations of Maxygen,Inc., +1-650-298-5853
Web site: http://www.maxygen.com/
